右心室功能及其与高级心力衰竭结果的关联
Kyle Steiger1, Naba Farooqui2, Jill M Killian3
1Department of Internal Medicine, Mayo Clinic, Rochester, MN. Electronic address: https://twitter.com/KyleGSteiger.
Mayo Clinic proceedings
|July 28, 2025
概括
在晚期心力衰竭中,中度至重度的右心室功能障碍是常见的,并且与更高的死亡风险有关. 然而,它并没有显著影响这些患者的住院率.
科学领域:
- 心脏病学 心脏病学
- 心脏衰竭研究研究
- 心声回声扫描 (Echocardiography) 是一种心声回声扫描.
背景情况:
- 右心室 (RV) 功能在心力衰竭管理中至关重要.
- 评估晚期 (D期) 心力衰竭的RV功能对于预后至关重要.
- 了解RV功能障碍的相关性和结果对于患者护理至关重要.
研究的目的:
- 确定与晚期心力衰竭中右室功能相关的临床因素.
- 在这个人群中调查RV功能与死亡/住院风险之间的关系.
主要方法:
- 对925名晚期心力衰竭患者 (2007-2018) 的回顾性队列研究.
- 通过心声回声学评估和分类的RV功能 (正常,轻度,中度至重度功能障碍).
- 考克斯和安德森-吉尔模型分析了与死亡和住院风险的关联.
主要成果:
- 71%的患者表现出一定程度的VR功能障碍.
- 中度至严重的RV功能障碍与所有原因 (aHR 1.30) 和心血管死亡率 (aHR 1.32) 的增加有关.
- 在RV功能和住院风险之间没有发现显著的关联.
结论:
- 右心室功能障碍在晚期心力衰竭中普遍存在,随着左心室射出分数的减少而恶化.
- 中度至重度的RV功能障碍预测了更高的死亡率,但不是住院治疗.
- 评估RV功能对于高级心力衰竭的风险分层至关重要.
相关概念视频
Mitral Regurgitation I: Introduction
56
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
56
Pathophysiology of Heart Failure
1.8K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.8K
Heart Failure II: Pathophysiology
44
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
44
Heart Failure VI: Adjunct Therapies
28
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
28
Heart Failure IV: Classification and Diagnostic Evaluation
33
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
33
Cardiomyopathy II: Dilated Cardiomyopathy
23
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
23


